Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus.
A vancomycin-intermediate Staphylococcus aureus (VISA) isolated from the blood of a 46-year-old patient with endocarditis was determined to be pulsed-field type USA300, daptomycin nonsusceptible, and positive for the Panton-Valentine leukocidin genes. Development of the VISA phenotype does not appear limited to traditional health care strains of S. aureus.
Centers for Disease Control and Prevention, Atlanta, GA 30033, USA. jhageman@cdc.gov
Jeffrey C
JC
Hageman
Jean
J
Patel
Patrick
P
Franklin
Karen
K
Miscavish
Linda
L
McDougal
David
D
Lonsway
Fazle N
FN
Khan
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D004697:Endocarditis, Bacterial / Q000097:blood / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D013203:Staphylococcal Infections / Q000097:blood / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000145:classification / Q000187:drug effects*; D014640:Vancomycin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D014640:Vancomycin